Inventor · disambiguated record
Patricia Forgez
Also filed as: FORGEZ PATRICIA
8 granted patents·10 pending applications·13 citations·filing 2009–2020
81Inventor score
Files withINST NAT SANTE RECH MED10FORGEZ PATRICIA3ALIFANO MARCO1ASSIST PUBL HOPITAUX DE PARIS1HRA PHARMA LAB1
Top patents by PatentIndex Score
18 records- 0181US10787506B2Anti-neurotensin long fragment antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2018·Granted Sep 29, 2020·1 cites·9 claims
- 0280US10174106B2Anti-neurotensin long fragment antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2015·Granted Jan 8, 2019·3 cites·7 claims
- 0377US8771691B2Methods for the treatment and the prognostic assessment of malignant pleural mesotheliomaFORGEZ PATRICIA·Filed 2009·Granted Jul 8, 2014·2 cites·5 claims
- 0473US8586043B2Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1FORGEZ PATRICIA·Filed 2010·Granted Nov 19, 2013·4 cites·1 claims
- 0569US10077303B2Anti-neurotensin antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2015·Granted Sep 18, 2018·1 cites·10 claims
- 0666US11820813B2Anti-neurotensin long fragment antibodies and uses thereofFORGEZ PATRICIA·Filed 2020·Granted Nov 21, 2023·0 cites·3 claims
- 0761US8529900B2Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancerALIFANO MARCO·Filed 2009·Granted Sep 10, 2013·2 cites·2 claims
- 0853US2014087387A1Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung CancerASSIST PUBL HOPITAUX DE PARIS·Filed 2013·Application pending·0 cites
- 0952US2014286967A1Methods for the Treatment and the Prognostic Assessment of Malignant Pleural MesotheliomaINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 1052US2019016798A1Anti-neurotensin antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1151US2015118154A1Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancerINST NAT SANTE RECH MED·Filed 2015·Application pending·0 cites
- 1251US2016024206A1Methods for the Treatment and the Prognostic Assessment of Malignant Pleural MesotheliomaINST NAT SANTE RECH MED·Filed 2015·Application pending·0 cites
- 1347US2022048995A1Use of an inhibitor of ntsr1 activation or expression for preventing weight loss, muscle loss, and protein blood level decrease in subjects in need thereofINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 1442US9814732B2Ulipristal acetate for prevention and treatment of breast tumorsLABORATOIRE HRA-PHARMA·Filed 2016·Granted Nov 14, 2017·0 cites·15 claims
- 1540US2015133418A1Ulipristal acetate for prevention and treatment of breast tumorsHRA PHARMA LAB·Filed 2013·Application pending·0 cites
- 1638US2014296281A1Methods for screening a brca1 loss-of-function in a subject suffering from a cancerINST NAT SANTE RECH MED·Filed 2012·Application pending·0 cites
- 1737US2018134788A1Methods and Pharmaceutical Compositions (NTSR1 Inhibitors) for the Treatment of Hepatocellular CarcinomasINST NAT SANTE RECH MED·Filed 2016·Application pending·0 cites
- 1827US2019015503A1Methods for the prognosis and treatment of endometrial carcinomaINSERM INSTITUT NATIONAL DE LA SANTE DE LA RECH MEDICALE·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patricia Forgez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →